Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2

Joseph Newman, Nazia Thakur, Thomas P. Peacock, Dagmara Bialy, Ahmed ME Elreafey, Carlijn Bogaardt, Daniel L. Horton, Sammy Ho, Thivya Kankeyan, Christine Carr, Katja Hoschler, Wendy S. Barclay, Gayatri Amirthalingam, Kevin Brown, Bryan Charleston, Dalan Bailey
doi: https://doi.org/10.1101/2021.12.23.21268293

Article usage

Article usage: December 2021 to November 2024

AbstractFullPdf
Dec 202113283635
Jan 202272844451
Feb 20221674083
Mar 20221491372
Apr 202289848
May 202285235
Jun 2022118637
Jul 20221241118
Aug 202242214
Sep 202269212
Oct 202257411
Nov 202233115
Dec 20223949
Jan 202377111
Feb 202345621
Mar 20232715
Apr 202331106
May 20231924
Jun 20231949
Jul 20231624
Aug 202338108
Sep 202382710
Oct 2023202118
Nov 20233761513
Dec 20236175
Jan 20241539
Feb 20241825
Mar 202416312
Apr 202416814
May 202415715
Jun 202417516
Jul 202416514
Aug 202442721
Sep 202415815
Oct 202424745
Nov 202414037
Back to top
Posted December 24, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Neutralising antibody activity against SARS-CoV-2 variants, including Omicron, in an elderly cohort vaccinated with BNT162b2
Joseph Newman, Nazia Thakur, Thomas P. Peacock, Dagmara Bialy, Ahmed ME Elreafey, Carlijn Bogaardt, Daniel L. Horton, Sammy Ho, Thivya Kankeyan, Christine Carr, Katja Hoschler, Wendy S. Barclay, Gayatri Amirthalingam, Kevin Brown, Bryan Charleston, Dalan Bailey
medRxiv 2021.12.23.21268293; doi: https://doi.org/10.1101/2021.12.23.21268293
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area